ERBB2 and neoplasm: Pre‐treatment with 120 mg/kg aspirin daily caused a significant decrease in primary tumour size (at time of resection) in both MDA‐MB‐231/LM2‐4/H2N and trastuzumab‐resistant HCC1954 Her2+ models.